Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “THE UNITED STATES OF AMERICA, as represented by th”

2,147 pharma patents match "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,147
Index total 30,257
Page 79 / 90

Quick answer

This filtered view shows 2,147 pharmaceutical patents matching "THE UNITED STATES OF AMERICA, as represented by th" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,147 results for “THE UNITED STATES OF AMERICA, as represented by th” · 30,257 patents in full index Clear search

  1. US 6685933

    Interferon &agr; hybrids

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2004 · Expires Jan 29, 2024

    expired

  2. US 6682758

    Water-insoluble drug delivery system

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 27, 2004 · Expires Jan 22, 2024

    expired

  3. US 6682741

    &bgr;2 microglobulin fusion proteins and high affinity variants

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 27, 2004 · Expires Jan 22, 2024

    expired

  4. US 6682728

    Efficient and selective adenoviral-mediated gene transfer into vascular neointima

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 27, 2004 · Expires Jan 22, 2024

    expired

  5. US 6680060

    Hepatitus A virus vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 20, 2004 · Expires Jan 15, 2024

    expired

  6. US 6680176

    Identification of candidate ligands which modulate antigen presenting cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 20, 2004 · Expires Jan 15, 2024

    expired

  7. US 6676973

    Method of treating ovarian cancers with cadmium

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 13, 2004 · Expires Jan 8, 2024

    expired

  8. US 6676936

    Chimeric and/or growth-restricted flaviviruses

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 13, 2004 · Expires Jan 8, 2024

    expired

  9. US 6673905

    Conjugation of biomolecules using Diels-Alder cycloaddition

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 6, 2004 · Expires Jan 1, 2024

    expired

  10. US 6673342

    Recombinant human IgA-J chain dimer

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 6, 2004 · Expires Jan 1, 2024

    expired

  11. US 6669962

    Starch microcapsules for delivery of active agents

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 30, 2003 · Expires Dec 25, 2023

    expired

  12. US 6670374

    Swainsonine compounds as inhibitors of toxin receptor expression

    The United States of America, as represented by the Secretary of Agriculture · Granted Dec 30, 2003 · Expires Dec 25, 2023

    expired

  13. US 6669935

    Delivery of therapeutic agents by gene therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 30, 2003 · Expires Dec 25, 2023

    expired

  14. US 6664374

    Polypeptides comprising IL-6 ligand-binding receptor domains

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  15. US 6664227

    Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  16. US 6664263

    1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 16, 2003 · Expires Dec 11, 2023

    expired

  17. US 6660488

    Antibodies for the alpha platelet-derived growth factor receptor

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 9, 2003 · Expires Dec 4, 2023

    expired

  18. US 6660750

    Flavopiridol methods and compositions for HIV therapy

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 9, 2003 · Expires Dec 4, 2023

    expired

  19. US 6660273

    Chimeric vaccine against tick-borne encephalitis virus

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 9, 2003 · Expires Dec 4, 2023

    expired

  20. US 6656706

    Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 2, 2003 · Expires Nov 27, 2023

    expired

  21. US 6656930

    Aralkyl diazabicycloalkane derivatives for CNS disorders

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 2, 2003 · Expires Nov 27, 2023

    expired

  22. US 6653505

    3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 25, 2003 · Expires Nov 20, 2023

    expired

  23. US 6653084

    Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 25, 2003 · Expires Nov 20, 2023

    expired

  24. US 6649411

    Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 18, 2003 · Expires Nov 13, 2023

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.